Britain's Got Talent final viewers disappointed as judges' wildcard act revealed
The wildcard act for the 2025 Britain's Got Talent final has been revealed, and fans are disappointed.
After a number of weeks of exciting semi-finals, there were various acts that missed out on the chance to perform in the final.
However, of all the acts, one is in the final as the wildcard.
But some fans have been left disappointed by the decision.
The wildcard act chosen for the 2025 Britain's Got Talent final is Han and Fran.
They were chosen as the 11th act by the judges.
Ant and Dec revealed the wildcard during the opening of the final, with Simon saying: "They got a massive vote from the public and therefore they deserve a shot in the final."
Viewers quickly voiced their opinion, with many taking to X (formerly Twitter) to share what they thought of the pair's return.
One said: "So has Simon just confirmed Han and Fran are the wild card because they got the highest 2nd place vote?"
Another added: "So many better acts should've been chosen as the wildcard."
"Why would you bring these two back?", a third said.
And our Wildcard is... HAN & FRAN!!! 🪩🎶 Will you take a chance on the disco divas? #BGT #BritainsGotTalent #BGTFinal pic.twitter.com/IkcATeXM9N
— BGT (@BGT) May 31, 2025
The vocalist duo quickly became fan favourites on their first appearance.
Despite performing a second ABBA medley, the duo were eliminated on last weekend's (May 24) semi-final.
They are vying to become the first Welsh winners of the show.
Recommended reading:
How to vote in the Britain's Got Talent 2025 Final on ITV tonight
'Unbelievable' act Simon Cowell credits for Britain's Got Talent's success
Britain's Got Talent's most viewed audition that led to over 1bn streams of song
The wildcard was first introduced back in series six when Alesha Dixon and David Walliams joined the panel
Each year, the judges have chosen one wildcard, with the exception of series nine and series 10, in which there was both a judges' and a public wildcard.
In series 14, there was no wildcard.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
5 minutes ago
- Bloomberg
Europe's Top Envoy Pitches for Deeper Philippine Defense Ties
Europe and the Philippines will set up a new 'security and defense dialogue,' officials said, in a move that comes as the European Union strengthens ties with Asian nations amid threats from China and Russia. 'This will be a dedicated platform through which we can deepen our cooperation, exchange expertise on security and defense and explore joint initiatives that contribute to the regional as well as global security,' Europe's top diplomat Kaja Kallas said Monday during a briefing with Foreign Affairs Secretary Enrique Manalo in Manila.
Yahoo
10 minutes ago
- Yahoo
EQT announces changes to the Executive Committee
Veteran EQT partner James Yu appointed to EQT's Executive Committee as Head of Client Relations and Capital Raising - overseeing EQT's client relations, capital raising and capital markets teams - as part of an introduction of a more agile and simplified operating model. Chief Commercial Officer Suzanne Donohoe, Bahare Haghshenas, Head of Sustainable Transformation, and Ricardo Reyes, Head of Communications & External Affairs, have decided to step off the Executive Committee and will leave EQT. STOCKHOLM, June 2, 2025 /PRNewswire/ -- EQT has today announced the appointment of James Yu, who joined EQT in 2013 and most recently served as Global Head of EQT Capital Markets, as Head of Client Relations and Capital Raising. The role brings together responsibility for two of EQT's key client facing teams – Client Relations & Capital Raising and Debt & Equity Capital Markets – as part of EQT's drive to constantly refine and strengthen its operating model. Yu will be the eighth member of EQT's Executive Committee, alongside CEO Per Franzén; Christina Drews, COO; Kim Henriksson, CFO; Gustav Segerberg, Head of Business Development and CEO Office; Jean Salata, Asia Chairperson and Head of Private Capital Asia; Lennart Blecher, Deputy Managing Partner and Chairperson of Real Assets; and Masoud Homayoun, Head of Infrastructure. Chief Commercial Officer Suzanne Donohoe, along with Bahare Haghshenas, Head of Sustainable Transformation, and Ricardo Reyes, Head of Communications & External Affairs, have stepped off the Executive Committee. Donohoe will remain involved to support select private wealth initiatives while Haghshenas will depart EQT later this year after a transition period. EQT's sustainability expertise remains a critical part of EQT's futureproofing capabilities and – going forward – will be even more closely integrated across the firm's investment strategies and operations. "EQT is always looking to stay ahead of the curve. The changes to the Executive Committee reflect a simplified operational model, putting us in an even stronger position to continue to deliver for our clients in today's market," said CEO and Managing Partner Per Franzén. "I'm excited to welcome James Yu to the Executive Committee. In this new role, Jim will lead our efforts towards a seamless client offering through closer collaboration across the EQT platform. By merging the client relations and capital market teams, we will be in a better position to drive further innovation at the intersection of capital raising and capital markets. I warmly thank Suzanne, Bahare and Ricardo for their contributions to EQT's growth journey to date and wish them all the best." ContactOlof Svensson, Head of Shareholder Relations, +46 72 989 09 15EQT Press Office, press@ +46 8 506 55 33 This information was brought to you by Cision The following files are available for download: PR_EQT Executive Committee changes_02.06.25 DSC02524 View original content:
Medscape
34 minutes ago
- Medscape
Remission, Attaining CV Risk Targets Drops CVD Risk in Lupus
Patients with systemic lupus erythematosus (SLE) had more than double the risk for atherosclerosis progression over 10 years than healthy control individuals, but maintaining cardiovascular risk factor (CVRF) targets and achieving sustained disease remission significantly reduced this risk. METHODOLOGY: Researchers collected carotid ultrasound measurements from 111 patients with SLE and 94 age- and sex-matched controls, including baseline measurements from 2012 to 2013 with follow-up assessments at 3, 7, and 10 years. They tracked carotid plaque progression, CVRF target attainment on the basis of the 2016 European Society of Cardiology Guidelines on cardiovascular disease (CVD) prevention and additional CVD risk modifiers, and incident CVD events over 10 years and looked for predictors of plaque progression. TAKEAWAY: Patients with SLE demonstrated a 2.3-fold higher risk for carotid plaque progression than healthy control individuals (incidence rate ratio [IRR], 2.26; 95% CI, 1.34-3.81; P = .002). = .002). Each CVRF maintained at target during the 10-year follow-up reduced plaque progression risk by 32% (IRR, 0.68; 95% CI, 0.53-0.89; P = .004). = .004). Achievement of definition of remission in SLE for ≥ 75% of follow-up decreased risk for plaque progression by 43% (IRR, 0.57; 95% CI, 0.34-0.95; P = .033). = .033). Persistent triple antiphospholipid antibody positivity increased 10-year risk for incident cardiovascular events in SLE more than sevenfold (hazard ratio, 7.52; P = .014). IN PRACTICE: 'Patients with SLE experience a 2.3-fold higher 10-year atherosclerosis progression risk than [healthy controls], which is significantly mitigated by sustained [cardiovascular risk factor] control and prolonged clinical remission,' the study authors wrote in the abstract. 'Carotid ultrasound may have an additive role in enhancing CVD risk assessment in patients with SLE.' SOURCE: Maria G. Tektonidou, MD, PhD, of the National and Kapodistrian University of Athens, Athens, Greece, presented the study at the 16th International Congress on Systemic Lupus Erythematosus in Toronto. LIMITATIONS: The study sample was relatively small. Carotid ultrasound is dependent on operator skill and experience, which can lead to interobserver and intraobserver variability. DISCLOSURES: Funding information for this research was not provided. Disclosure information for the authors was not available.
